Cargando…
Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684796/ https://www.ncbi.nlm.nih.gov/pubmed/38033432 http://dx.doi.org/10.1016/j.lanwpc.2023.100945 |
| _version_ | 1785151486913675264 |
|---|---|
| author | Li, Yanhua Qiao, Shitong Dong, Lei Zhang, Rong Li, Ruiqiang Qin, Shijie Yu, Dongshan Liu, Xianfei Li, Ying Ma, Yueyun Zhao, Xin Gao, George Fu |
| author_facet | Li, Yanhua Qiao, Shitong Dong, Lei Zhang, Rong Li, Ruiqiang Qin, Shijie Yu, Dongshan Liu, Xianfei Li, Ying Ma, Yueyun Zhao, Xin Gao, George Fu |
| author_sort | Li, Yanhua |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10684796 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106847962023-11-30 Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China Li, Yanhua Qiao, Shitong Dong, Lei Zhang, Rong Li, Ruiqiang Qin, Shijie Yu, Dongshan Liu, Xianfei Li, Ying Ma, Yueyun Zhao, Xin Gao, George Fu Lancet Reg Health West Pac Correspondence Elsevier 2023-11-15 /pmc/articles/PMC10684796/ /pubmed/38033432 http://dx.doi.org/10.1016/j.lanwpc.2023.100945 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Correspondence Li, Yanhua Qiao, Shitong Dong, Lei Zhang, Rong Li, Ruiqiang Qin, Shijie Yu, Dongshan Liu, Xianfei Li, Ying Ma, Yueyun Zhao, Xin Gao, George Fu Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China |
| title | Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China |
| title_full | Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China |
| title_fullStr | Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China |
| title_full_unstemmed | Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China |
| title_short | Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China |
| title_sort | antibody response assessment of immediate breakthrough infections after zero-covid policy adjustment in china |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684796/ https://www.ncbi.nlm.nih.gov/pubmed/38033432 http://dx.doi.org/10.1016/j.lanwpc.2023.100945 |
| work_keys_str_mv | AT liyanhua antibodyresponseassessmentofimmediatebreakthroughinfectionsafterzerocovidpolicyadjustmentinchina AT qiaoshitong antibodyresponseassessmentofimmediatebreakthroughinfectionsafterzerocovidpolicyadjustmentinchina AT donglei antibodyresponseassessmentofimmediatebreakthroughinfectionsafterzerocovidpolicyadjustmentinchina AT zhangrong antibodyresponseassessmentofimmediatebreakthroughinfectionsafterzerocovidpolicyadjustmentinchina AT liruiqiang antibodyresponseassessmentofimmediatebreakthroughinfectionsafterzerocovidpolicyadjustmentinchina AT qinshijie antibodyresponseassessmentofimmediatebreakthroughinfectionsafterzerocovidpolicyadjustmentinchina AT yudongshan antibodyresponseassessmentofimmediatebreakthroughinfectionsafterzerocovidpolicyadjustmentinchina AT liuxianfei antibodyresponseassessmentofimmediatebreakthroughinfectionsafterzerocovidpolicyadjustmentinchina AT liying antibodyresponseassessmentofimmediatebreakthroughinfectionsafterzerocovidpolicyadjustmentinchina AT mayueyun antibodyresponseassessmentofimmediatebreakthroughinfectionsafterzerocovidpolicyadjustmentinchina AT zhaoxin antibodyresponseassessmentofimmediatebreakthroughinfectionsafterzerocovidpolicyadjustmentinchina AT gaogeorgefu antibodyresponseassessmentofimmediatebreakthroughinfectionsafterzerocovidpolicyadjustmentinchina |